Charles River Falls 4% After Missing Estimates (CRL)

Shares of Charles River Laboratories International CRL are currently down 3.99% at $29.84 per share during Monday afternoon trading. Today's trading range for shares of Charles River Laboratories International has been between $29.06 and $30.50 per share. The consensus price target of analysts covering the company's stock is $$40.63 per share. Volume of 3.6 million shares shares is already more than double the daily average volume of 1.4 million shares shares. Charles River Laboratories International (CRL) released financial results on Monday morning that missed Wall Street estimates. Charles River Laboratories International reported 2nd quarter adjusted earnings of 49 cents per share, on revenue of $292.1 million. A poll of analysts conducted by Thomson Reuters showed an average Wall Street estimate of expected earnings of 50 cents per share, on revenue of $305.56 million. “We are disappointed that market demand for outsourced preclinical services did not rebound during the second quarter as we had previously expected," said chairman, president and chief executive officer James C. Foster. Read more from Benzinga's Company news.